References
- Kouraklis G, Theocharis S. Histone deacetylase inhibitors and anticancer therapy. Curr Med Chem—Anti-cancer Agents 2002; 2: 477–84.
- Zwiebel JA. New agents for acute myelogenous leukemia. Leukemia 2000; 14: 488–90.
- Timmerman S, Lehrmann H, Popesskaya A, Harel-Bellan A. Histone acetylation and disease. Cell Mol Life Sci 2001; 58: 728–36.
- Marks P, Rifkind R, Richon VM, Breslow R, Miller T, Kelly WK. Histone deacetylases and cancer; causes and therapies. Nat Rev Cancer 2001; 1:194–9.